2019 Annual Meeting | How to Build Clinical Research Studies in Private Practice

Date Tuesday 05/07/19

Time 02:00 PM - 02:30 PM EDT Add To Calendar

Session Format This program will be presented both in-person and online

On Demand This program is not expected to be available in the meeting's On Demand product.

Event Type Hubs (Innovation)

Director(s) David C. Weisman, MD

Topic(s) Experiential Learning Area

Learning Objectives Participants will become familiar with the basics of good clinical practice, the role and responsibility of being a principal investigator at a site level, and practical advice for starting clinical trials.

CME Available 0.00 credit

Core Competencies Patient Care & Procedural Skills, Professionalism, Practice-based Learning and Improvement

Program Level Introductory

Recommended Audience Fellow, Resident, General Neurologist, Specialist Neurologist

Teaching Styles Didactic, Other

Program Materials Program Evaluations

Event Timeline
02:00 PM - 02:30 PM EDT	Speaker	How to Build Clinical Research Studies in Private Practice David C. Weisman, MD

Faculty Disclosures
David C. Weisman, MD	Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Roche. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Iqvia. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Acumen. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Eisai. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Novartis. Dr. Weisman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for eisai. Dr. Weisman has received personal compensation in the range of $5,000-$9,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Lantheus. Dr. Weisman has received personal compensation in the range of $50,000-$99,999 for serving on a Speakers Bureau for Eisai. Dr. Weisman has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Lilly. The institution of Dr. Weisman has received research support from Eisai. The institution of Dr. Weisman has received research support from Biogen. The institution of Dr. Weisman has received research support from Roche. The institution of Dr. Weisman has received research support from Vivoryon. The institution of Dr. Weisman has received research support from Lilly. The institution of Dr. Weisman has received research support from Acumen. The institution of Dr. Weisman has received research support from Cerevel. The institution of Dr. Weisman has received research support from Sage. The institution of Dr. Weisman has received research support from Annovis. The institution of Dr. Weisman has received research support from Serono. The institution of Dr. Weisman has received research support from Acadia. The institution of Dr. Weisman has received research support from Alnylam. The institution of Dr. Weisman has received research support from Ventus. The institution of Dr. Weisman has received research support from Cognition. Dr. Weisman has received intellectual property interests from a discovery or technology relating to health care. Dr. Weisman has received intellectual property interests from a discovery or technology relating to health care. Dr. Weisman has received personal compensation in the range of $500-$4,999 for serving as a Peripheral and Central Nervous System Drugs Advisory Committee with FDA.

��ɫ��

��ɫ��